| S No | API | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
US  |
EU  |
CA  |
JP  |
AU | KR  |
UA  |
CN  |
BR | RU  |
||
| 1 | Amlodipine Besylate |  |
|
|
|
|
|
|
|
|
|
| 2 | S(-)Amlodipine Besilate | U/R | |
|
U/F | |
|||||
| 3 | Amlodipine Maleate | |
|
|
U/R | ||||||
| 4 | Cetirizine Dihydrochloride | |
|
|
|
|
|
U/R | |
||
| 5 | Levocetirizine Dihydrochloride | |
|
|
|
|
U/F | U/R | |
||
| 6 | Raloxifene Hcl | |
|
|
|
||||||
| 7 | Hydroxyzine HCL | Filed | |
|
U/F | ||||||
| 8 | Telmisartan | Filed | U/R | ||||||||
| 9 | Clopidogrel Bisulphate Form II | |
U/F: Under Filing
U/R: Under Review
New Products (Under Development)
| Product | Therapeutic | Product Status |
|---|---|---|
| Famotidine | Anit-Ulcerative | DMF by Dec-24 |
| Lercanidipine | Anit-Hypertensive | DMF by Apr-25 |
| Empagliflozin | Anit-Diabetic | DMF by Sep-25 |
